EUVIMEDEUVIMED entdecken
Crossref

Impact of symptomatic multiple sclerosis therapy on pregnancy outcome

Laura Witt iD, Sabrina Haben, Karen Dost-Kovalsky, Natalia Friedmann, Nadine Bast iD, Theresa Oganowski, Ralf Gold, Sandra Thiel, Kerstin Hellwig

Multiple Sclerosis Journal · 2024

DOI: 10.1177/13524585241293363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multiple Sclerosis Journal, 2024. Verfasst von Laura Witt und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St. Josef-Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Pregnancy Outcome, Pregnancy Complications, Multiple Sclerosis, Registries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Biogen, Roche, Sanofi Genzyme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Information on symptomatic therapy (ST) use in women of childbearing age with multiple sclerosis is sparse, and data on the impact of ST pregnancy exposure on pregnancy outcome are lacking.

Objective

To investigate (1) ST use patterns pre-conception, during pregnancy and postpartum and (2) pregnancy outcomes.

Methods

Pregnancy data from the German Multiple Sclerosis and Pregnancy Registry were analyzed for the ST use from pre-conception to postpartum. Pregnancy outcomes were compared between ST-exposed ( n = 282) and matched (disease modifying therapy and age) ST-naive (n = 536) pregnancies.

Results

Of 2,449 pregnancies, 1,053 (43.0%) received ST anytime between pre-conception and postpartum, 282 (11.5%) at pre-conception and during pregnancy. The most commonly used drug classes were antidepressants (24.8%), analgetics (31.0%), and anticonvulsives (8.7%). Exposure to ST during pregnancy did not result in an increased incidence of adverse pregnancy outcomes, major congenital abnormalities, or pregnancy complications.

Conclusion

Nearly 50% of women used ST between pre-conception and postpartum, but only 12% pre-conception and during pregnancy. ST use during pregnancy did not adversely affect pregnancy outcomes in our cohort. More data are needed to analyze the effect of ST on pregnancy and fetal outcomes stratified by drug to improve recommendations for ST use in family planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy OutcomePregnancy ComplicationsMultiple SclerosisRegistriesHumansFemalePregnancyAdultPostpartum PeriodAntidepressive AgentsYoung AdultAnticonvulsantsGermany

Stichwörter der Autor:innen

MSMS symptomsMultiple sclerosispregnancypregnancy outcomessymptomatic therapy

Substanzen

Antidepressive AgentsAnticonvulsants

Autor:innen und Institutionen

  • Department of Neurology, St. Josef-Hospital, Katholisches Klinikum Bochum, Ruhr-University Bochum, Bochum, Germany.
  • Institute of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Neurologische Klinik, St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum.

ORCID-Profile: Laura Witt, Nadine Bast

Förderung

  • Biogen
  • Roche
  • Sanofi Genzyme
  • Hexal AG
  • Innovation Fund of the Federal Joint Committee
  • Merck
  • Teva Pharmaceutical Industries
  • Novartis

Zitieren

APA

Witt, L., Haben, S., Dost-Kovalsky, K., Friedmann, N., Bast, N., Oganowski, T., Gold, R., Thiel, S., & Hellwig, K. (2024). Impact of symptomatic multiple sclerosis therapy on pregnancy outcome. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585241293363

Vancouver

Witt L, Haben S, Dost-Kovalsky K, Friedmann N, Bast N, Oganowski T, et al. Impact of symptomatic multiple sclerosis therapy on pregnancy outcome. Multiple Sclerosis Journal. 2024. doi:10.1177/13524585241293363

BibTeX
@article{Witt2024,
  author = {Witt, Laura and Haben, Sabrina and Dost-Kovalsky, Karen and Friedmann, Natalia and Bast, Nadine and Oganowski, Theresa and Gold, Ralf and Thiel, Sandra and Hellwig, Kerstin},
  title = {Impact of symptomatic multiple sclerosis therapy on pregnancy outcome},
  journal = {Multiple Sclerosis Journal},
  year = {2024},
  doi = {10.1177/13524585241293363}
}
Kostenlos starten →